CANNABIS SCIENCE, INC.
FORM NT 10-Q
(Notification that form 10-Q will be submitted late)
Filed 08/14/09 for the Period Ending 06/30/09
Address 6946 N Academy Blvd
Suite B No. 254
Colorado Springs, CO 80918
Telephone 1-888-889-0888
CIK 0001024626
Symbol CBIS
SIC Code 1311 Crude Petroleum and Natural Gas
Industry Biotechnology & Drugs
Sector Healthcare
Fiscal Year 12/31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
Commission File Number : 000-28911
Notification Of Late Filing
(Check One) : ( ) Form 10-K ( ) Form 10-KSB ( ) Form 20-F
( ) Form 11-K ( X ) Form 10-Q ( ) Form N-SAR
For the Fiscal Year Ended : June 30, 2009
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates :
Part I - Registration Information
CANNABIS SCIENCE, INC.
Full Name of Registrant
6946 N Academy Blvd, Suite B No. 254, Colorado Springs, CO 80918
Address of Principal Executive Office
Part II Rule 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate.)
( X ) (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without unreasonable effort or
expense.
( X ) (b) The subject annual report, semi-annual report,
transition report on Form 10-K or Form 10-KSB, Form 20-F, 11-K,
or Form N-SAR, or portion thereof will be filed on or before the
fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or
portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
(c) The accountant?s statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
Part III Narrative
State below in reasonable detail the reasons why Form 10-K or 10-KSB,
Form 20-F, 11-K, 10-Q, 10-D, N-CSR, or the transition report portion
thereof could not be filed within the prescribed time period.
The Registrant is unable to file, without unreasonable effort and
expense, its Form 10-Q for the period ended June 30, 2009 because
its auditors have not yet had an opportunity to complete their
review of these financial statements. The Registrant anticipates that
it will file its Form 10-Q within the five-day grace period provided
by the Exchange Act Rule 12b-25.
Part IV Other Information
(1) Name and telephone number of person to contact in regard to
this notification.
Robert Melamede 1-888-889-0888
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or
15(d) of the Securities Exchange Act of 1934 or section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for
such shorter period that the registrant was required to file such
report(s) been filed? If the answer is no, identify report(s).
( X ) Yes ( ) No
(3) Is it anticipated that any significant change in results of
operation from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the
subject report or portion thereof? ( ) Yes ( X ) No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
CANNABIS SCIENCE, INC.
(Name of Registrant as specified in charter) has caused this notification
to be signed on its behalf by the undersigned thereunto duly authorized.
Date : August 14, 2009 By: /s/ Robert Melamede
-------------------
Robert Melamede
Chief Executive Officer